VP, Global Vaccine Strategy Lead, Shingles

Purpose

The VP, Global Medical Strategy Lead is a key senior business leadership role, reporting to the VP and Head of Vaccines Global Medical Affairs who is a key member of GSK’s Global Medical Leadership Team.  The leader will have full responsibility for the Global Medical Strategy for an asset or portfolio of related assets in certain circumstances.  The Global Medical Strategy Lead will lead the translation of our science to shape the practice of medicine and deliver positive health impact for patients by providing healthcare decision-makers around the world with the evidence and confidence they need on GSK therapies/Vaccines and influencing internal stakeholders with medical insight and expertise related to Development and Commercialization strategies. The role will be accountable for the Medical strategic direction of an Asset or Portfolio of assets and the matrix leadership of the Global Asset/Vaccine Medical Leadership Team, integrating innovative strategies that advance patient care.  The role will partner with key markets to ensure that their insights are used to inform all evidence, asset/vaccine development and strategic deliverables as well as partnering across Commercial and R&D to deliver value for patients.    

In addition to leading the Global Asset Medical Leadership team, the incumbent will be a member of several additional matrix teams including the Vaccine Development Team and the Vaccine Commercial Team where he or she will provide Medical insight and expertise to inform and influence evidence generation and scientific communication plans across the lifecycle to optimize patient impact within markets.

A key focus of the role is to develop and stretch self and team to be best in industry at delivering impact for patients and improving patient care paradigms.  The leader must exemplify GSK values and leadership behaviors.

Responsibilities

Medical and Scientific Business Leadership

• Maximise the positive impact for patients and GSK from early development to maturity (defined as no further significant clinical evidence generation).
• Accountable for developing and delivering the Global medical product strategy which shape the practice of medicine and associated Global deliverables enabling prioritized LOCs to execute the strategy and deliver positive patient impact locally
• Acting as a partner with the Vaccine Development Lead and Vaccines Commercialisation Lead, ensure integrated and thoughtful insights from across a diverse stakeholder set contribute to shaping the medicines/vaccine’s vision, development strategy and clinical development in the early phases of development, and for refining medical strategy as clinical evidence is generated.
• Ensure that medical insights from key countries are used to inform all evidence, product development, and franchise strategy deliverables
• Ensure that the evidence generation plan aligns to the IEP and maximizes the product competitiveness and addresses prioritized evidence gaps from launch through lifecycle management for key LOCs
• Oversee asset budget to ensure that resources are deployed against the highest the highest impact tactics
• Ensure that Global deliverables are produced on time based on market needs
• Use a Global mindset, incorporating local perspectives, to strategy development and decision making. Work across different major markets to understand their needs and balance options to achieve the set-out goals.

Performance culture

• Maintains the patient at the center of everything we do.
• Full immersion in the science, disease area and business to be a true and equal partner to R&D, Commercial and Key LOCs.
• Outstanding matrix leadership through the creation of a collaborative and cross-functional environment by fostering shared accountability and responsibility for delivery of specific goals and projects, and encouraging employees to work with diverse skill sets and learn from each other
• Seek out, actively listen to and understand the needs of key markets and ensure they are appropriately reflected in the global strategy, inclusive of evidence generation and all other deliverables.
• Assess and understands the external environment, inclusive of the competitor landscape, to bring insights together to develop a clear, simple, compelling Medical strategy to improve outcomes for patients  
• Adopt a visionary and intuitive mindset, to anticipate current and future market value-drivers and evidence gaps and seek innovative solutions to them to support the long-term ambition for the asset/vaccine and its ultimate benefit for patients
• Quickly adapt to unexpected external changes, understanding impact to strategy and ability to articulate implications for both R&D and commercial
• Integrate and synthesize deep understanding of the end